Zhang Yun-Kai - College of Pharmacy and Health Sciences, St. John's University

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 75 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Molecular Mechanisms of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

Zhenfang Du, Hongfei Kan, Jinghan Sun, Yue Liu, Jiahui Gu, Shugela Akemujiang, Yudi Zou, Lufan Jiang, Qinzhuo Wang,Chen Li, Lei Luo,Yunkai Zhang,Hong Fan, Pengfei Luo, Bo Wang

Drug resistance updates reviews and commentaries in antimicrobial and anticancer chemotherapy (2025): 101266-101266

Cited0Views0WOSBibtex

Supplementary Table S5 from ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation

Hui Yuwen,Huajing Wang,Tengteng Li,Yijing Ren,Yun-kai Zhang, Peng Chen,Ao Sun,Gang Bian,Bohua Li,David Flowers,Marc Presler,Kalyanasundaram Subramanian,Jia Xue, Jingjing Wang,Kevin Lynch,Jay Mei,Xiaowen He,Bo Shan,Bing Hou

crossref（2024）

Cited0Views0Bibtex

Supplementary Table S4 from ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation

crossref（2024）

Cited0Views0Bibtex

Data from ATG-101 is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity Through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation

Yuwen Hui,Huajing Wang,Tengteng Li,Yijing Ren,Yun-kai Zhang,Peng Chen,Ao Sun,Gang Bian,Bohua Li,David Flowers,Marc Presler,Kalyanasundaram Subramanian,Jia Xue, Jingjing Wang,Kevin Lynch,Jay Mei,Xiaowen He,Bo Shan,Bing Hou

CANCER RESEARCHno. 10 (2024): 1680-1698

Cited4Views0WOSBibtex

Supplementary Table S6 from ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation

crossref（2024）

Cited0Views0Bibtex

Phosphorylation of PHF2 by AMPK Releases the Repressive H3K9me2 and Inhibits Cancer Metastasis

Ying Dong,Hao Hu,Xuan Zhang,Yunkai Zhang, Xin Sun,Hanlin Wang,Weijuan Kan,Min-jia Tan,Hong Shi,Yi Zang,Jia Li

Signal Transduction and Targeted Therapy（2023）

Cited20Views0WOSNATUREBibtex

Supplementary Figure Legends from On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating Mutation

Benjamin P. Brown,Yun-Kai Zhang,David Westover,Yingjun Yan,Huan Qiao,Vincent Huang,Zhenfang Du,Jarrod A. Smith, Jeffrey S. Ross,Vincent A. Miller, Siraj Ali,Lyudmila Bazhenova, Alexa B. Schrock,Jens Meiler, Christine M. Lovly

openalex（2023）

Cited0Views0Bibtex

1337 the Preclinical Characterization and Translational Research of ATG-031, a First-in-class Humanized Anti-Cd24 Antibody, for the Treatment of Solid Tumors and Hematological Malignancies

Jishun Chen,Min Deng, Yun Liu,Peng Chen,Linjie Tian,Rong Guo,Bing Hou,Jay Mei,Bo Shan,Yunkai Zhang,Jiamei Luo

Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn